rose 4% in early premarket trade as it said late Tuesday that early-stage data suggests its COVID-19 vaccine can generate neutralizing antibodies in older and elderly adults at levels comparable to those in younger adults.
Intraday Data provided by FACTSET and subject to terms of use
Historical and current end-of-day data provided by FACTSET
Intraday data delayed at least 15 minutes or per exchange requirements